Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Memosharp is an Ayurvedic dietary supplement formulated to support cognitive health, memory, focus, and concentration. Developed by Charak Pharma (under its Vedistry brand), the formulation contains a synergistic blend of five traditional herbs: Brahmi (*Bacopa monnieri*), Mandukaparni (*Centella asiatica*), Yashtimadhu (*Glycyrrhiza glabra*), Amalaki (*Phyllanthus emblica*), and Haridra (*Curcuma longa*). These ingredients work together to enhance alertness, improve memory recall, and provide antioxidant protection to safeguard brain cells from oxidative stress and cellular damage. It is marketed as a non-habit-forming daily brain booster suitable for students, professionals, and adults experiencing age-related cognitive decline.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Memosharp.